Navigation Links
Hutchinson Center president elected to American Academy of Art and Sciences
Date:4/17/2012

SEATTLE Larry Corey, M.D., president and director of Fred Hutchinson Cancer Research Center, has been elected to membership in the American Academy of Arts and Sciences, one of the nation's oldest and most prestigious honorary societies and independent policy-research centers.

"I'm extremely honored to be in the same company as so many highly-regarded people in the fields of science, medicine and the arts," Corey said. "I'm also very proud to join the six other Hutchinson Center scientists who preceded me as members of the academy."

Corey has led the Hutchinson Center since January 2011 and has held other leadership positions there since 1996, first as head of infectious disease sciences in the Clinical Research Division and later as senior vice president and co-director of the Center's Vaccine and Infectious Disease Division.

He is the Hutchinson Center's second president to be elected to the Academy. Yeast geneticist Lee Hartwell, Ph.D., a 2001 Nobel laureate, was elected in 1998. He led the Center from 1997 until 2010.

Corey is among 220 leaders in the sciences, social sciences, humanities, arts, business and public affairs who have been elected to the American Academy of Arts and Sciences 2012 class of fellows. This year's class includes winners of the National Medal of Science, the Lasker Award, the Pulitzer Prize, MacArthur and Guggenheim fellowships, the Kennedy Center Honors, as well as Grammy, Emmy, Academy and Tony awards.

The new class will be inducted at a ceremony Oct. 6 at the Academy's headquarters in Cambridge, Mass.

An internationally renowned expert in virology, immunology and vaccine development, Corey's research has focused on herpes viruses, HIV and other viral infections, particularly those associated with cancer. He also is principal investigator of the Hutchinson Center-based HIV Vaccine Trials Network, an international collaboration of scientists and institutions that combines clinical trials and laboratory-based studies to accelerate the development of HIV vaccines.

Corey is a professor of laboratory medicine and medicine, adjunct professor of pediatrics and microbiology, and holder of the Lawrence Corey Endowed Chair in Medical Virology at the University of Washington. He is also an infectious disease physician at Seattle Cancer Care Alliance.

Besides his leadership role, Corey is recognized as one of the most highly cited and funded investigators in the United States. He has authored 12 books and more than 600 scientific publications and is a member of numerous scientific committees and editorial boards.

His honors and awards include election in 2008 to the Institute of Medicine, a prestigious branch of the National Academy of Sciences. He is a fellow of the Infectious Diseases Society of America and is a member of the American Society for Clinical Investigation, the American Epidemiological Society and the Association of American Physicians.

In addition to Corey and Hartwell, other Academy members at the Hutchinson Center are Linda B. Buck, Ph.D., who in 2004 received the Nobel Prize in physiology or medicine for her groundbreaking work on the network responsible for our sense of smell; Mark T. Groudine, M.D., Ph.D., deputy director of the Hutchinson Center and former director of its Basic Sciences Division; Robert Eisenman, Ph.D., a leader in the field of oncogenes, aberrantly regulated genes that cause cancer; cell biologist Daniel Gottschling, Ph.D., a member of the Basic Sciences Division; and the late Harold M. Weintraub, Ph.D., an international leader in the field of molecular biology.

Since its founding in 1780, the Academy has elected leading "thinkers and doers" from each generation, including George Washington and Benjamin Franklin in the eighteenth century, Daniel Webster and Ralph Waldo Emerson in the nineteenth, and Albert Einstein and Winston Churchill in the twentieth. The current membership includes more than 250 Nobel laureates and more than 60 Pulitzer Prize winners.


'/>"/>

Contact: Dean Forbes
dforbes@fhcrc.org
206-667-2896
Fred Hutchinson Cancer Research Center
Source:Eurekalert

Related medicine news :

1. Hutchinson Center receives $10.24 million from NIH for Latina breast cancer research
2. Hutchinson Center and China CDC sign agreement for research and training collaboration
3. Fred Hutchinson Cancer Research Center scientist receives Presidential Early Career Award
4. NCI awards $11.5 million to Fred Hutchinson Cancer Research Center to lead breast cancer consortium
5. Fred Hutchinson Cancer Research Center to lead Immunotherapy Clinical Trials Network
6. Shanghai CDC and Hutchinson Center establish Shanghai Breast Health Resource Center
7. Hutchinson Center receives $8.2M to coordinate obesity and cancer consortium
8. Fred Hutchinson Cancer Research Center to co-lead 1 of 5 NCI-funded proteomics research centers
9. Hutchinson Center breaks ground for first collaborative cancer center in sub-Saharan Africa
10. Hutchinson Center scientists break through pancreas cancer treatment barrier
11. Hutchinson Center and TGen scientists discover potential break through in pancreatic cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland ... iHire in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness ... & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of ...
(Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... feeding the Frederick area economy by obtaining investment capital for emerging technology companies. ... 2½ years that have already resulted in more than a million dollars of ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 26, 2016 One of Australia,s ... formation of a new biotechnology company, Noxopharm Limited [ABN 50 608 ... IPO and to list on the ASX. Noxopharm is ... to enter a Phase 1 clinical study later this year. ... one of the biggest problems facing cancer patients - the ability ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
Breaking Medicine Technology: